Cargando…

Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1

Unique purine-rich mRNA sequences embedded in the coding sequences of a distinct group of gammaherpesvirus maintenance proteins underlie the ability of the latently infected cell to minimize immune recognition. The Epstein-Barr virus nuclear antigen, EBNA1, a well characterized lymphocryptovirus mai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tellam, Judy T., Lekieffre, Lea, Zhong, Jie, Lynn, David J., Khanna, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531512/ https://www.ncbi.nlm.nih.gov/pubmed/23300450 http://dx.doi.org/10.1371/journal.ppat.1003112

Ejemplares similares

mRNA Structural Constraints on EBNA1 Synthesis Impact on In Vivo Antigen Presentation and Early Priming of CD8(+) T Cells
por: Tellam, Judy T., et al.
Publicado: (2014)

Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex‐I mediated antigen presentation
por: Murat, Pierre, et al.
Publicado: (2014)

Endogenous Presentation of CD8(+) T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
por: Tellam, Judy, et al.
Publicado: (2004)

'Off-the-shelf’ allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies
por: Sinha, Debottam, et al.
Publicado: (2021)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam
por: Thuan, LD, et al.
Publicado: (2019)

The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
por: Styles, Christine T., et al.
Publicado: (2018)

Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
por: Apcher, Sebastien, et al.
Publicado: (2010)

Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
por: Bhattacharjee, Shaoni, et al.
Publicado: (2016)

Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth
por: Noh, Ka-Won, et al.
Publicado: (2016)

Basophils control T cell priming through soluble mediators rather than antigen presentation
por: Möbs, Christian, et al.
Publicado: (2023)

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
por: Paschos, Kostas, et al.
Publicado: (2012)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentation
por: McDonnell, Alison M., et al.
Publicado: (2012)

Antigen-Binding Properties of Monoclonal Antibodies Reactive with EBNA1 and Use in Immunoaffinity Chromatography
por: Duellman, Sarah J., et al.
Publicado: (2009)

Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
por: Frappier, Lori
Publicado: (2012)

A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers
por: Hosseini Tabatabaie, Fatemeh, et al.
Publicado: (2023)

Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
por: Bhatt, Kunal H., et al.
Publicado: (2020)

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
por: Ai, Junhong, et al.
Publicado: (2012)

EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
por: Huo, Shaofen, et al.
Publicado: (2020)

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice
por: Zhang, Xiang, et al.
Publicado: (2021)

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis
por: Napoletani, Giorgia, et al.
Publicado: (2023)

Correction: Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
por: Bhatt, Kunal H., et al.
Publicado: (2022)

Conservation of vaccine antigen sequences encoded by sequenced strains of Streptococcus equi subsp. equi
por: Frosth, Sara, et al.
Publicado: (2022)

Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation
por: Jha, Hem Chandra, et al.
Publicado: (2015)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival
por: Bhattacharjee, Shaoni, et al.
Publicado: (2018)

Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a “Bookmarking” Oncoprotein that Alters the Host Cell Epigenotype?
por: Niller, Hans Helmut, et al.
Publicado: (2012)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022)

Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen.
por: Sakakura, C., et al.
Publicado: (1994)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency
por: Klein, Eva, et al.
Publicado: (2013)

T cell contact with Ia antigens on nonhemopoietic cells in vivo can lead to immunity rather than tolerance
Publicado: (1991)

Place cells on a maze encode routes rather than destinations
por: Grieves, Roddy M, et al.
Publicado: (2016)

Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families
por: Chang, C M, et al.
Publicado: (2012)

Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
por: Hui, Kwai Fung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ot3qnlblfr3bjsf0fh5khaqvas